Syndax Pharmaceuticals Inc
Ticker: 1395937
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
83.30
+14.4%+81.6%
Expenditure
125.19
+11.0%+21.2%
Net Profit
-49.43
-0.1%+18.6%
OPM %
-50.30%
+4.65pp+49.70pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingSNDX
20269Nov
Board Meeting
CFO Transition - Aaron A. Ondrey appointed as Chief Financia…
SEC Filing ↗ Board MeetingSNDX
202610Jun
Board Meeting
Annual Meeting of Stockholders held on June 10, 2026, where …
SEC Filing ↗